|
Session 1: Terminology and Pronouns |
|
Enduring |
|
$0.00 |
|
Keeping up with the Chemos Series: Mirvetuximab Soravtansine - Preparing to Give It (Part 1) |
|
Enduring |
|
$0.00 |
|
SGO Talent Show |
|
Enduring |
|
$0.00 |
|
Session 6: Considerations and Risks for Gynecologic and Breast/Chest Cancers in Transgender Patients |
|
Enduring |
|
$0.00 |
|
Scientific Plenary III: Farr Nezhat Surgical Innovation Session |
|
Enduring |
|
$0.00 |
|
SGO Wellness Curriculum |
|
Enduring |
|
$0.00 |
|
Education Forum I: Your Coding Questions Answered |
|
Enduring |
|
$0.00 |
|
Keeping up with the Chemos Series: Trametinib - Administration (Part 2) |
|
Enduring |
|
$0.00 |
|
Use of PARPi in Gynecologic Oncology |
|
Enduring |
|
$0.00 |
|
SGO/ACCC Antineoplastic Flashcards |
|
Enduring |
|
$0.00 |
|
ERAS Guidelines: Surgical Site Infection Bundle (SSI) Bundle |
|
Enduring |
|
$0.00 |
|
The Big Reveal: 2020 State of the Society Survey- Patterns, Progress and Pathways to your Professional Future |
|
Enduring |
|
$0.00 |
|
Menopause with Mary Jane Minkin: HRT For Menopause Management in Benign Patients |
|
Enduring |
|
$0.00 |
|
Best of ESMO 2022 Podcast |
|
Enduring |
|
$0.00 |
|
Immunotherapy Part 3: Common Controversies and Remaining Questions |
|
Enduring |
|
$0.00 |
Facebook
Twitter
LinkedIn
Forward